The European Medicines Agency has finalised a safety review of medicines containing sibutramine. The Agency’s Committee for Medicinal Products for Human Use (CHMP) concluded that the risks of these medicines are greater than their benefits and recommended the suspension of marketing authorisations for these medicines across the European Union. Sibutramine-containing medicines are authorised as …

Originally posted here: 
European Medicines Agency Recommends Suspension Of Marketing Authorisations For Sibutramine (Medical News Today)

Tags: are-greater, article directory, Article Marketing, committee, gruber, human, safety-review, the-best, will-add

This entry was posted on January 22, 2010 at 7:29 am. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Posted in Article Marketing by No Comments Yet